The cellular and molecular events that drive early innate lympoid cell (ILC) development remain poorly understood. We show that transcription factor TCF-1 is required for the efficient generation of all known adult ILC subsets and their precursors. Using novel reporter mice, we identified a new subset of early ILC progenitors (EILP) that expressed high amounts of TCF-1. EILP lacked efficient T and B lymphocyte potential, but efficiently gave rise to NK cells and all known adult helper-ILC lineages, indicating that they are the earliest identified ILC-committed progenitors. Our results suggest that upregulation of TCF-1 expression denotes the earliest stage of ILC fate specification. The discovery of EILP provides a basis to decipher additional signals that specify the ILC fate.
Introduction
Innate lymphoid cells (ILC) lack adaptive antigen receptors, but functionally and transcriptionally resemble subsets of effector T cells [1] [2] [3] [4] . They include conventional Natural Killer (NK) cells and three subsets of cytokine-producing helper cells, ILC1, ILC2, and ILC3 5 . ILC are important players in tissue homeostasis, host defense and tumor survelliance 2 . However, the cellular and molecular events that underlie ILC fate specification and commitment remain poorly understood.
ILC derive from bone marrow (BM) lymphoid progenitors [6] [7] [8] , but little is known about their further lineage progression steps. Previous studies have identified several candidate ILC progenitor subsets in the BM, but none efficiently gave rise to all four ILC lineages at the clonal level [9] [10] [11] . A developmental history of PLZF expression was detected in several cytokine-producing helper-ILC subsets but not conventional NK cells 11 . BM PLZF + Thy-1 + IL-7Rα + α 4 β 7 + progenitors efficiently matured into several cytokine-producing helper-ILC subsets, but not conventional DX5 + NK cells and CD4 + LTi-like cells 11 . A similar BM progenitor subset, identified as Id2 + Thy-1 + IL-7Rα + α 4 β 7 + Lin − cells, are termed common helper-innate lymphoid cells progenitors (CHILP). CHILP contain both PLZF + and PLZF − progenitors. CHILP gave rise to all helper-ILC subsets, but not conventional NK cells 10 . The majority of single BM PLZF + progenitors or CHILP gave rise to one or two ILC lineages, but lacked multi-ILC lineage potential when assessed in vitro, indicating that they may represent more mature ILC progenitor stage(s) 10, 11 . A different progenitor subset defined as CXCR6 + IL-7Rα + alpha-LP may give rise to conventional NK and also helper ILC subsets 9 . But these CXCR6 + IL-7Rα + alpha-LP were extremely rare (around 50 cells per entire mouse), and only 2.5% of them (1 cell per entire mouse) efficiently gave rise to all four ILC lineages at the clonal level 9 . Hence, physiological early ILC progenitors for all four adult ILC lineages remain to be identified.
T cell factor-1 (TCF-1, encoded by the Tcf7 gene) is a sequence-specific high-mobility group (HMG) transcription factor. TCF-1 was cloned from T cells 12, 13 , and it plays an essential role in T cell lineage specification and differentiation [14] [15] [16] [17] [18] [19] . Recent work from us and others also implicated TCF-1 in the biology of ILC [20] [21] [22] [23] [24] . Mucosal ILC2 were greatly reduced in Tcf7 −/− mice, and therefore these mice can not clear nematodes or mount innate type-2 immune reponses to airway protease challenge 20, 21 . The number of small intestinal laminal propria (SiLP) ILC3 was also significantly reduced in Tcf7 −/− mice. In addition, the number of NK cells was modestly reduced in Tcf7 −/− mice, and Tcf7 −/− NK cells did not express the receptor Ly49a [22] [23] [24] . Hence, TCF-1 is an essential controller in the generation or function of ILC. The precise role of TCF-1 in early ILC develpoment, however, remains largely unknown.
Here we report that TCF-1 promotes early ILC development in the BM, and further identify BM early innate lymphoid cell progenitors that express TCF-1 and efficiently develop into all known ILC lineages at the clonal level. We showed that TCF-1 is required for the efficient generation of all known adult mature ILC subsets as well as the ILC precursors CHILP and NKP. Using newly-generated Tcf7 GFP reporter mice, we identified novel early innate lymphoid progenitors that express high levels of TCF-1 but lack surface markers of adaptive and innate lymphocyte lineages. These early innate lymphoid progenitors closely resemble bone marrow lymphoid progenitors at the transcriptome level, but lack efficient T and B lymphocyte potential. Instead, they efficiently gave rise to various ILC lineages, including conventional NK cells as well as cytokine-producing helper ILC at the clonal level, indicating that they are the earliest identifiable ILC progenitors. Our data implicate TCF-1 in very early stages of BM ILC specification. Identification of early innate lymphoid progenitors will provide a basis to understand the molecular signals that drive early ILC development.
Results

TCF-1 promotes early ILC development
To understand the specific developmental stage(s) at which TCF-1 acts to promote ILC development, we examined the previously described PLZF-expressing common helper ILC progenitors (CHILP) 10, 11 and also CD122-expressing NK cell progenitors (NKP) 25 in the bone marrow (BM) of Tcf7 −/− mice (Exon VII targeted) 19 . Both PLZF + CHILP and NKP were greatly reduced in Tcf7 −/− mice, indicating that TCF-1 was required for early ILC development in the bone marrow (Fig. 1a, b , c). The previously described pre-NKP 26 , rNKP 26 , and pre-pro-NKP 27 were also greatly reduced in Tcf7 −/− mice ( Supplementary Fig.  S1a ). Despite the near absence of CHILP and NKP in Tcf7 −/− mice, some mature NK cells, ILC1 and ILC3 persisted in the peripheral tissues of these mice 21, 23 ( Supplementary Fig.  S1b , c). To more precisely define the requirement for TCF-1 in ILC development, we purified BM multipotent LSK progenitors (Lin − Sca-1 + Kit + Thy-1 − ) from donor Tcf7 −/−19 and control littermates (B6 mice, CD45.2) as well as competitor CD45.1 wild-type (WT) mice, and generated competitive LSK chimeras in irradiated recipient B6 congenic CD45.1 mice. Tcf7 −/− LSK-derived donor populations were nearly devoid of all known mature ILC subsets in the peripheral tissues (Fig. 1d , e, Supplementary Fig. S1d , e), indicating that TCF-1 is expressed in hematopoietic precursors of all these lineages but that the requirement is most strict when competition is present. The results further established that the requirement for TCF-1 in the generation of CHILP and NKP was cell-intrinsic ( Fig. 1f, g ). Together, these data indicated a role for TCF-1 in promoting early ILC development in the bone marrow, and suggested that TCF-1 might be expressed and act at an early stage of innate cell fate specification.
Identification of an early innate lymphoid progenitor
Recent work has described several subsets of IL-7Rα-expressing BM ILC progenitors, but none of them efficiently gave rise to all four ILC lineages at the clonal level [9] [10] [11] . To search for TCF-1-expressing progenitors, we generated a Tcf7-GFP reporter allele by inserting GFP-coding sequences in the first intron of the Tcf7 gene (called Tcf7 GFP , Supplementary  Fig. S2a ,b,c). In Tcf7 GFP mice, GFP was specifically expressed in T lymphocytes that expressed high levels of TCF-1, but not in B lymphocytes that lacked TCF-1 expression ( Supplementary Fig. S2d ). Mature ILC at peripheral sites also expressed various levels of TCF-1 ( Supplementary Fig. S2e ).
Because ILC development does not require the thymus, we initially searched for possible novel TCF-1 + ILC progenitors in the BM. The Lineage-negative (Lin − ) cells in the BM of Tcf7 GFP mice contained rare but distinct GFP + subsets (Fig. 2a) . We fractioned the GFP + Lin − BM progenitors based on the surface expression of IL-7Rα and Thy-1. Consistent with previous reports [9] [10] [11] 28 , the IL-7Rα + Thy-1 + GFP + subsets included previously described CHILP and ILC2P, which expressed TCF-1. Interestingly, we also identified a novel BM subset that expressed high levels of TCF-1, but were negative or low for surface expression of IL-7Rα and Thy-1 (Fig. 2a) , and thus differed from previously described candidate progenitor populations [9] [10] [11] 25 . Unlike previously described alpha-LP, NKP, pre-NKP, rNKP, pre-pro NKP, or CHILP [9] [10] [11] [25] [26] [27] , these IL-7Rα neg/lo Thy-1 − TCF-1 + Lin − cells did not express detectable CD122 or CXCR6 on the cell surface (Fig. 2b) , and only expressed low levels of mRNAs for Il7r and Zbtb16 (encoding PLZF) expression (Fig. 2c) , confirming that they are a previously unrecognized cell subset. These candidate early innate lymphoid progenitors (EILP) developed into all four ILC lineages on OP9 stroma, but lacked efficient B or T cell potential in vitro ( Supplementary Fig. S3 a, b, c) . EILP lacked expression of Cd3e, confirming that they were not T cells (Fig. 2c) ; and of B cell lineage transcription factors such as Ebf1 (Fig. 2c) . EILP, however, expressed high amounts of Nfil3 and Tox (Fig. 2c) , two other transcription factors implicated in early ILC development 9, [29] [30] [31] [32] , and so exhibited features of early innate lymphoid cell progenitors.
We compared EILP with other early hematopoietic progenitors. Like CLP, EILP expressed low levels of Kit and Sca-1 (Fig. 3a) . EILP also expressed a low level of Flt3 (Fig. 3a) . 
EILP are clonogenic progenitors to all known adult ILC subsets
To determine the in vivo lineage potential of EILP, we intravenously transferred EILP or TCF-1 + CHILP together with competitor CLP into unirradiated Rag2 −/− gc −/− recipient mice. We analyzed lymphocyte reconstitution at 3-6 weeks post-transplantation. EILP failed to generate B lymphocytes, and generated very few T cells (Fig. 4a, b) . They, however, gave rise to all four ILC lineages examined in vivo (Fig. 4a, 10, 11 , TCF-1 + CHILP efficiently gave rise to ILC1, 2, 3, but not conventional NK cells, indicating that they were more downstream helper ILC progenitors ( Fig. 4a, b) . Together, these data established that EILPs are ILC-committed progenitors possessing the capability to give rise to all known adult ILC lineages in vivo.
We considered whether the inability of EILP to reconstitute T lineage cells after intravenous transfer might be due to their incapability to home to the thymus, rather than lack of T cell potential. To better determine the T lineage potential of EILP, we performed intrathymic transfer of EILP or control CLP. Whereas CLP generated CD4 + CD8 + (double-positive, DP) thymocytes as expected, EILP lacked T lineage potential even when placed inside the thymus, (Fig. 3d , e). These data, together with our observation that EILP failed to give rise to T cells on OP-DL1 stroma ( Supplementary Fig. S3b ), indicated that EILP lack T cell lineage potential.
We next sought to determine the lineage potential of EILPs at the clonal level in vitro. We tested a number of different cytokine conditions based on previous reports [8] [9] [10] [11] 34 to identify a cytokine combination (SCF, IL2, IL-7) with which EILP displayed the greatest proliferative expansion (Supplementary Fig. S4a ). We plated single EILP isolated by cell sorting on OP9 stromal cells in each well of 96-well plates. Plating efficiencies in these experiments were approximately 50% ( Supplementary Fig. S4b ). (Fig. 5a, b) . The remaining wells contained a wide variety of combinations of ILC progeny, including a few ILC1-3 tri-lineage helper ILC progenitor that may overlap with the previously described PLZF + progenitors ( 10,11 , Fig. 5a ). (Fig. 5c ).
Our identification of EILP in the bone marrow indicated that the earliest stages of ILC specification and commitment occur at this site. To understand whether the thymus might also be a suitable site for early ILC development, we searched for EILP in the thymus. A few thymocytes displayed the phenotype of EILP (Lin − TCF-1 + Thy-1 − IL-7Rα neg/lo , Supplementary Fig. S4d ), but they failed to efficiently generate ILC in vitro ( Supplementary  Fig. S4e ). Hence, functional EILP are rare in the thymus, if they exist. These data indicated that although upregulated expression of TCF-1 occurs both during early ILC development in the BM and early T cell development in the thymus, other important differences must exist between lymphocyte development at these sites.
Id2 is dispensable for the generation of EILP
In addition to TCF-1, the transcriptional inhibitor of E proteins Id2 is also required for the generation of all known ILC [38] [39] [40] . However, previous studies suggested that ILC fate specification might initiate independently of Id2 9,10,41 . Indeed, NKP remained present in Id2 −/− mice 41 , but were greatly reduced in Tcf7 −/− mice, suggesting that TCF-1 might act prior to Id2 during early ILC development (Fig. 1a,b) . EILP expressed Id2 mRNA, but the levels were lower as compared with CHILP and ILC2P (Fig. 2c) . To determine whether Id2 was required for EILP generation, we generated Id2 −/− Tcf7 GFP mice. EILP clearly persisted in Id2 −/− mice, although their numbers were reduced 50% (Fig. 6a, b) . CHILP and ILC2P were absent, as expected 10 . Id2 −/− EILP expressed Nfil3 and TOX at a slightly lower level than Id2 +/+ EILP (Fig. 6c) . Hence TCF-1 is expressed prior to the dependence on Id2 during the emergence of the earliest progenitors for NK cells and ILC in early BM hematopoiesis.
To determine whether Id2 might control the lineage commitment of EILP, we cultured Id2 −/− EILP under B or T lymphocyte differentiation conditions with OP9 or OP9-DL1 stroma. Id2 −/− EILP failed to give rise to B or T cells in vitro, indicating that other molecules can repress T/B lymphocyte potential in EILP ( Supplementary Fig. S5a, b) . We examined the expression of other Id proteins in Id2 −/− EILP. In the absence of Id2, Id1 expression was increased 3-fold, and Id3 expression was increased 11-fold in EILP (Fig.  6c) . Hence, Id2 possibly participates in ILC fate commitment, but other Id proteins may be up-regulated in their expression to compensate for the loss of Id2.
Discussion
The present study identifies an early innate lymphoid cell progenitor. EILP express TCF-1 and are clonogenic progenitors for both NK cells and all known adult helper-ILC lineages. EILP were identified in the BM, persisted in the absence of Id2, and were most closely related to CLP at the transcriptome level, indicating that TCF-1 might identify the earliest steps of BM ILC development, prior to the requirement of Id2. NKP and CHILP were nearly absent in adult Tcf7 −/− mice, indicating that these innate progenitors are likely downstream of EILP, and that TCF-1 is required for their generation.
Interestingly, although CHILP and NKP were nearly completely lacking in adult Tcf7 −/− mice, many mature ILC developed and were present in these mice in the absence of competition 20, 21, 24 . However, the remaining ILC In Tcf7 −/− mice may be functionally compromised 20, 21, 24 . The remaining NK cells in Tcf7 −/− mice do not express Ly49a 24 ; the remaining Tcf7 −/− ILC2 do not make IL-13 in responses to in vivo intranasal protease challenge 20, 21 ; and the development of Peyer's patches is severely compromised in Tcf7 −/− mice despite a near-normal number of CD4 + LTi-like cells 21 . How these abnormal ILC developed in Tcf7 −/− mice remains to be further determined; compensatory upregulation of Lef-1 expression is one possible mechanism 14, 20, 42 . Nevertheless, our data from competitive LSK chimeras indicated that the TCF-1-dependent pathway is the predominant pathway that replenishes normal, functional intact ILC in adult mice.
EILP are close to CLP at the transcriptome level, but EILP lack efficient T and B lymphocyte potentials and express very low levels of IL-7Rα. ETP, the earliest identified T-lineage progenitors, are also low for Il7r mRNA expression; but most ETP were marked with a history of IL-7Rα expression in Il7r-Cre/Rosa YFP mice 43, 44 . Whether EILP also have a history of IL-7Rα expression, and what controls the dynamic expression of IL-7Rα during early ILC and T lineage development, are interesting topics for future investigation. One possibility is that downregulation of IL-7Rα expression might help quench B celllymphoid fate to allow entry into the ILC as well as T cell lineages 45 .
Previous studies indicated that NK cell fate specification initiates before the requirement for Id2 in NK development 9 
Generation of Tcf7-GFP reporter mouse strain
Targeting construct design: The Tcf7 gene is expressed in multiple isoforms due to different promoter usage and alternative splicing. The full length TCF-1 isoforms (p45 and p42) are transcribed from an upstream promoter utilizing Exon 1, and the short isoforms (p33 and p30) are transcribed from Exon 3 (Extended Fig. 2a ). To generate a Tcf7-GFP reporter allele, we inserted an EGFP expression cassette and a neomycin-resistant gene (NEO) cassette into the least conserved region in the first intron of the Tcf7 gene. The EGFP expression cassette contains a strong En2 gene splicing acceptor (En2-SA) to facilitate splicing of Tcf7 exon 1 to the reporter, an internal ribosome entry site (IRES) to facilitate independent translation of EGFP, and the EGFP cDNA followed by poly-adenylation sequence. Two Frt sites were inserted to flank the EGFP and NEO cassettes One LoxP site was inserted immediately downstream of the second Frt site in intron 1, and another LoxP site was inserted into the least conserved region in intron 2. These features, although not used in this report, were designed to remove the EGFP and NEO cassettes with Flippase, converting the Tcf7-GFP reporter allele to Tcf7 Exon 2-floxed allele, so as to conditionally target the TCF-1 long isoforms.
The targeting construct was assembled using the recombineering approach. All sequences surrounding the insertion sites were verified to ensure no unwanted mutations had occurred. The targeting construct was electroporated into C57Bl/6 embryonic stem (ES) cells, and the ES clones with expected homologous recombination were screened by Southern blotting (Extended Fig.2b and 2c ). Blastocyst injection of the ES cells was performed at the Transgenic Animal Model Core, the University of Michigan. The chimeras containing the targeted allele were crossed with C57Bl/6 mice to achieve germline transmission.
Isolation of hematopoietic cells in periphery tissues
For isolation of lung hematopoietic cells, lungs were perfused by injecting 10 ml PBS into the right ventricle of the heart. Lungs were carefully cut into small fragments and digested in HBSS containing 0.025 mg/ml Liberase D (Roche Diagnostics) and 10 U/ml DNase 1 (Roche Diagnostics). Cells were filtered using a cell strainer.
For isolation of intestinal lymphocytes, payer's patches were removed from the small intestines. The small intestines were opened and the contents were emptied. The small intestines were cut into 1-cm pieces and were shaken at 37 °C for 30 mins in RPMI 1640 containing 1% FCS (Invitrogen), 1mM EDTA (Invitrogen), and 1mM DTT (SigmaAldrich). †The tissues were washed and subsequently digested with HBSS containing 0.025 mg/ml Liberase D (Roche Diagnostics) and 10 U/ml DNase 1 (Roche Diagnostics) by shaking at 37 °C for 30 mins. The digested tissues were filtered. Lamina Propria Lymphocytes were isolated by 40% Percoll.
Flow Cytometry and Cell Sorting
All antibodies (Abs) used in this study were purchased from eBioscience. Clones for Abs can be found in Supplementary Table 1 . Flow cytometric analysis was performed on a LSR-II (BD Biosciences). Intracellular staining was performed using Fix/Perm Kit (eBioscience) according to manufacture's instructions.
Adoptive Transfer
For competitive LSK chimeras, 5000 Sorted bone marrow LSK progenitors from donor mice (CD45.2) were mixed with 5000 competitor wildtype LSK cells (CD45.1) and together injected into lethally irradiated (950 rads) wildtype recipient mice (CD45.1). Reconstitution of ILC in the recipient mice was examined at 12-16 weeks post-transfer.
For adoptive transfer of purified BM progenitors, 1000 EILP or TCF-1 + CHILP from Tcf7 GFP mice were mixed with bone marrow equivalent numbers (around 20,000) of competitor CLP (CD45.1), and together transferred intravenously into Rag2 −/− gc −/− mice. Reconstitution of lymphocytes were examined at 3-6 weeks post-transfer.
Cell Culture
Bone marrow progenitors were sorted by flow cytometric cell sorting. For ILC differentiation assays, progenitors were cultured in DMEM medium containing 20% FCS, 30ng/ml SCF, 30ng/ml IL-7 and 30ng/ml IL-2 on OP9-stromal cells. Cytokines were purchased from PeproTech or R&D. Progenitor differentiation was examined at 7-14 days after culture. For B cell differentiation assays, progenitors were co-cultured with OP9-stromal cells in the presence of IL-7 (10ng/ml) and FL (5ng/ml) for 7 days. For T cell differentiation assays, progentiors were cultured with OP9-DL1 stromal cells in the presence of IL-7 (1ng/ml or 10 ng/ml) and FL (5ng/ml) for 7 days. For myeloid differentiation, progenitors were co-cultured with OP9-stroma in the presence of IL-7 (1ng/ml) and FL(5ng/ml) for 4 days as desribed 46, 47 . For assessing DC differentiation, progenitors were cultured in suspension with IL-1β (2 ng/ml), IL-3 (400 ng/ml), IL-7 (10ng/ml), SCF (10ng/ ml), FL (100ng/ml), and TNF-α (1 ng/ml) for 4 days as previously described 48 . , and the quality of the RNA was tested on a bioanalyser. Biotinylated cDNA were prepared using Encore Biotin Module kit (Nugen) from 5.5 ug RNA according to the manufacture's instructions. 2.5ug/ul cDNA were hybrizied at 16 hours at 45 C on Affymetrix Mouse Gene 2.0 ST Array. The microarrays were then washed and stained with streptavidin-phycoerythrin. GeneChips were scanned using the GeneArray Scanner 3000 7G. The data were analysed using Affymetrix Expression Console with the default analysis settings. Gene signal values for the arrays were normalized and log2-transformed. Heatmaps were generated using the pheatmap R package (version 1.0.2) 49 .
Microarray
Statistics
Statistical analysis was performed on groups with limited variance. Comparison between two groups was performed using two-sided Student's t Test. The difference was considered significant with a p value lower than 0.05.
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